Last Updated: August 19, 2026

CLINICAL TRIALS PROFILE FOR PARDOPRUNOX

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Pardoprunox

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00269516 ↗	SLV308 for Treatment of Patients With Early Parkinson's Disease	Completed	Solvay Pharmaceuticals	Phase 3	This study is a multicenter, randomized, double blind, parallel group study of 6 months' treatment with SLV308 administered as a monotherapy in patients with early stage PD. An open label safety extension to this study is planned as a separate protocol for patients who are willing and eligible to participate.
NCT00332917 ↗	An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients	Completed	Solvay Pharmaceuticals	Phase 3	This is a multicenter, 6 months open label safety extension study for all patients who are willing and eligible to continue from the pivotal, double-blind S308.3.001 trial
NCT00335374 ↗	An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients	Completed	Solvay Pharmaceuticals	Phase 3	This is a multicenter, 6 months open label safety extension study for all patients who are willing and eligible to continue from the pivotal, double-blind S308.3.003 trial
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Pardoprunox

Condition Name

Chart
Table

Condition Name
Intervention	Trials
Advanced Stage Parkinson's Disease	3
Early Stage Parkinson's Disease	3
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH
Intervention	Trials
Parkinson Disease	6
Dyskinesias	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Pardoprunox

Trials by Country

Map
Table

Trials by Country
Location	Trials
United States	65
Bulgaria	4
Colombia	4
Russian Federation	4
Chile	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State
Location	Trials
Ohio	5
North Carolina	5
Florida	5
California	5
Texas	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Pardoprunox

Clinical Trial Phase

Chart
Table

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 3	5
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	5
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Pardoprunox

Sponsor Name

Chart
Table

Sponsor Name
Sponsor	Trials
Solvay Pharmaceuticals	5
Abbott Products	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type
Sponsor	Trials
Industry	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.